Post-earnings recap
Reported
Mon, Feb 13, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported a strong EPS performance, exceeding expectations by nearly 24%. The stock reacted positively, rising by 0.38%. The lack of revenue data and future guidance may leave some investors cautious, but the earnings beat suggests solid underlying performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.69 | N/A | +23.88% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on earnings performance. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing investments in growth areas.